Sleep Improvement Therapy Affects Pregnancy Outcomes in Chinese Singletons and Twins by Improving Sleep Quality
Launched by JUN WEI · Nov 11, 2024
Trial Information
Current as of June 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- • Inclusion Criteria: (1) Pregnant women aged 18-45 years. (2) Diagnosed with single or twin pregnancy within 12 weeks of pregnancy, report sleep quality problems, agree to participate in the study and sign the informed consent -
- • Exclusion Criteria:Have a prior serious underlying medical condition (e.g., diabetes, heart disease), mental illness, or other serious sleep disorder
- • -
About Jun Wei
Jun Wei is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodology and ethical standards, Jun Wei collaborates with healthcare professionals and research institutions to design and conduct clinical trials that adhere to regulatory guidelines. The organization prioritizes patient safety and data integrity, leveraging cutting-edge technologies and analytical approaches to ensure robust results. Jun Wei is driven by a vision of transforming healthcare through evidence-based advancements and is dedicated to bringing novel treatments from the lab to the clinic.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shenyang, Liaoning, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported